Kahansim Makshwar Luka, Pam Victor Chung, Mutihir Josiah Turi
Department of Obstetrics and Gynaecology, Jos University Teaching Hospital, Jos, Nigeria.
Niger Med J. 2022 Sep 11;63(2):163-168. doi: 10.60787/NMJ-63-2-90. eCollection 2022 Mar-Apr.
Contraceptive implants are popular methods among women accessing family planning in Jos. Women appear to be using these methods for longer periods despite adequate counselling including the use for a maximum period prescribed by the manufacturers.
This was a retrospective, cross sectional study of all clients who had ImplanonR classic removed between May 2006 and December 2019. The register of acceptors of the implant was retrieved and relevant variables collated and analyzed for age, duration of use of the implant and the indication for removal. The data was analyzed using the Stata statistical software version 14, College Station, Texas, USA.
A total of 1,805 implants were inserted, when all of them would have been removed, only 596(33%) were documented to have been removed. The mean age of the clients was 31.031 ± 5.56 years, range 18-51 years. The mean duration of use of ImplanonR was 29.370 ± 11.756 months, range 0.5-72months. About 83(13.9%) implants were used beyond the expected duration of use of 36 months. By the 3rd, 4th, and 5th years, 86.1%, 97.5% and 99.2% had had the implants removed. Clients used the method beyond the stipulated expiration of the implants, up to twice the period expected. There was no failure or pregnancy recorded.
About one-sixth of women extended the use of ImplanonR implants. This may be more as only 33.0% of them returned for removal at the facility where it was inserted. However, there was no pregnancy recorded in this group of women despite the extended duration of use.
避孕植入剂是乔斯地区寻求计划生育服务的女性中常用的方法。尽管接受了包括按照制造商规定的最长使用期限使用在内的充分咨询,但女性似乎使用这些方法的时间更长。
这是一项对2006年5月至2019年12月期间取出ImplanonR经典款植入剂的所有客户进行的回顾性横断面研究。检索了植入剂接受者登记册,并对年龄、植入剂使用时长及取出指征等相关变量进行整理和分析。使用美国得克萨斯州大学城的Stata统计软件版本14对数据进行分析。
共植入了1805枚植入剂,当所有植入剂都应被取出时,仅有596枚(33%)有取出记录。客户的平均年龄为31.031±5.56岁,年龄范围为18至51岁。ImplanonR的平均使用时长为29.370±11.756个月,范围为0.5至72个月。约83枚(13.9%)植入剂的使用时间超过了预期的36个月使用期限。到第3年、第4年和第5年,分别有86.1%、97.5%和99.2%的植入剂已被取出。客户使用该方法的时间超过了植入剂规定的有效期,长达预期时间的两倍。未记录到失败或怀孕情况。
约六分之一的女性延长了ImplanonR植入剂的使用时间。这一比例可能更高,因为只有33.0%的女性返回植入机构取出植入剂。然而,尽管使用时间延长,但该组女性中未记录到怀孕情况。